5/24
07:00 am
bpth
Bio-Path Holdings to Present Data at 2024 European Hematology Association Congress
Low
Report
Bio-Path Holdings to Present Data at 2024 European Hematology Association Congress
5/23
05:03 pm
bpth
Bio-Path Holdings to Present Data at American Society of Clinical Oncology (ASCO) Annual Meeting [Yahoo! Finance]
Low
Report
Bio-Path Holdings to Present Data at American Society of Clinical Oncology (ASCO) Annual Meeting [Yahoo! Finance]
5/23
05:00 pm
bpth
Bio-Path Holdings to Present Data at American Society of Clinical Oncology (ASCO) Annual Meeting
Low
Report
Bio-Path Holdings to Present Data at American Society of Clinical Oncology (ASCO) Annual Meeting
5/15
07:12 am
bpth
Bio-Path Holdings Reports First Quarter 2024 Financial Results [Yahoo! Finance]
High
Report
Bio-Path Holdings Reports First Quarter 2024 Financial Results [Yahoo! Finance]
5/15
07:00 am
bpth
Bio-Path Holdings Reports First Quarter 2024 Financial Results
High
Report
Bio-Path Holdings Reports First Quarter 2024 Financial Results
5/8
07:08 am
bpth
Bio-Path Holdings to Announce First Quarter 2024 Financial Results on May 15, 2024 [Yahoo! Finance]
Low
Report
Bio-Path Holdings to Announce First Quarter 2024 Financial Results on May 15, 2024 [Yahoo! Finance]
5/8
07:00 am
bpth
Bio-Path Holdings to Announce First Quarter 2024 Financial Results on May 15, 2024
Medium
Report
Bio-Path Holdings to Announce First Quarter 2024 Financial Results on May 15, 2024
5/2
05:06 am
bpth
Bio-Path Holdings, Inc. (NASDAQ: BPTH) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
Bio-Path Holdings, Inc. (NASDAQ: BPTH) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
4/24
02:10 am
bpth
Bio-Path Holdings, Inc. (NASDAQ: BPTH) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
Bio-Path Holdings, Inc. (NASDAQ: BPTH) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
4/19
12:19 pm
bpth
Bio-Path Holdings, Inc. Announces Closing of $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules [Yahoo! Finance]
Low
Report
Bio-Path Holdings, Inc. Announces Closing of $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules [Yahoo! Finance]
4/19
12:14 pm
bpth
Bio-Path (BPTH) Rises on Upbeat Updates From Blood Cancer Study [Yahoo! Finance]
Medium
Report
Bio-Path (BPTH) Rises on Upbeat Updates From Blood Cancer Study [Yahoo! Finance]
4/19
12:14 pm
bpth
Bio-Path Holdings, Inc. Announces Closing of $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Low
Report
Bio-Path Holdings, Inc. Announces Closing of $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4/18
02:32 pm
bpth
Bio-Path announces $1.2M registered direct offering priced at-the-market [Seeking Alpha]
Medium
Report
Bio-Path announces $1.2M registered direct offering priced at-the-market [Seeking Alpha]
4/18
02:12 pm
bpth
Bio-Path Holdings, Inc. (NASDAQ: BPTH) had its "buy" rating re-affirmed by analysts at Roth Mkm. They now have a $40.00 price target on the stock.
High
Report
Bio-Path Holdings, Inc. (NASDAQ: BPTH) had its "buy" rating re-affirmed by analysts at Roth Mkm. They now have a $40.00 price target on the stock.
4/18
02:09 pm
bpth
Bio-Path Holdings, Inc. Announces $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules [Yahoo! Finance]
High
Report
Bio-Path Holdings, Inc. Announces $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules [Yahoo! Finance]
4/18
01:57 pm
bpth
Bio-Path Holdings, Inc. Announces $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
High
Report
Bio-Path Holdings, Inc. Announces $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4/18
12:39 pm
bpth
CNN values your feedback [CNN]
High
Report
CNN values your feedback [CNN]
4/18
10:56 am
bpth
Bio-Path shares rally after clinical trial progress of BP1002 [Seeking Alpha]
High
Report
Bio-Path shares rally after clinical trial progress of BP1002 [Seeking Alpha]
4/18
07:23 am
bpth
Bio-Path Holdings Announces Successful Completion of Higher Dose Second Cohort in Phase 1/1b Clinical Trial of BP1002 in Refractory/Relapsed Acute Myeloid Leukemia (AML) Patients [Yahoo! Finance]
High
Report
Bio-Path Holdings Announces Successful Completion of Higher Dose Second Cohort in Phase 1/1b Clinical Trial of BP1002 in Refractory/Relapsed Acute Myeloid Leukemia (AML) Patients [Yahoo! Finance]
4/18
07:00 am
bpth
Bio-Path Holdings Announces Successful Completion of Higher Dose Second Cohort in Phase 1/1b Clinical Trial of BP1002 in Refractory/Relapsed Acute Myeloid Leukemia (AML) Patients
High
Report
Bio-Path Holdings Announces Successful Completion of Higher Dose Second Cohort in Phase 1/1b Clinical Trial of BP1002 in Refractory/Relapsed Acute Myeloid Leukemia (AML) Patients
4/16
02:07 am
bpth
Bio-Path Holdings, Inc. (NASDAQ: BPTH) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
Bio-Path Holdings, Inc. (NASDAQ: BPTH) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
4/15
07:10 am
bpth
Bio-Path Holdings Expands Global Patent Portfolio [Yahoo! Finance]
Low
Report
Bio-Path Holdings Expands Global Patent Portfolio [Yahoo! Finance]
4/15
07:00 am
bpth
Bio-Path Holdings Expands Global Patent Portfolio
Low
Report
Bio-Path Holdings Expands Global Patent Portfolio
4/8
02:04 am
bpth
Bio-Path Holdings, Inc. (NASDAQ: BPTH) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
Bio-Path Holdings, Inc. (NASDAQ: BPTH) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
4/2
07:05 am
bpth
Bio-Path Holdings Provides 2024 Clinical and Operational Update [Yahoo! Finance]
High
Report
Bio-Path Holdings Provides 2024 Clinical and Operational Update [Yahoo! Finance]